Drug-related index likely to gain in second half

Published: 2004-06-17 07:00:00

Updated: 2004-06-17 07:00:00

With a wide variety of drug-related index showing signs of improvement from the first quarter of this year drug shipment, drug retail sales, and health care services, these factors will likely feed optimism that the market is heading toward business pick-up in the second quarter. Domestic pharma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK